March 2008 Sosei Announces Temporary Halt to AD 923 CBP Phase III Studies in Europe February 2008 Sosei Announces Initiation of Phase III Trial for NorLevo® February 2008 Summary of Consolidated Financial Results for the 3Q ended 31st December 2007 (abridged English version ) February 2008 Sosei Announces Start of AD 923 Phase III Studies in Europe January 2008 Update of NVA237 and QVA149 Development Programme     2008 | 2007 | 2006 | 2005 | 2004